
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatDXCM bounced from roughly $60 in early May to $75.56 now off strong Q1 results, wider G7 15 Day rollout, and a margin expansion story that got fresh backing at Investor Day.
The stock has the potential to go down if it loses $72, with a retrace toward $68 to $65 in play. Any sign that growth, execution, or quality improvements from management are slipping would speed up that downside.
If DXCM holds the $72 to $73 area, a move back toward $80 to $85 is on the table as traders lean into better margins and steady CGM demand. Resistance near $76 is the first hurdle.
We don't currently have information about DexCom Inc.'s earnings.